Celexa is a prescription-only antidepressant that contains the active ingredient citalopram. It belongs to the class of selective serotonin reuptake inhibitors (SSRI) and is supplied as an oral pill in strengths of 10 mg and 20 mg. In Hong Kong, Celexa is regulated by the Department of Health and can be dispensed only with a valid medical prescription.
Citalopram belongs to the SSRI family. It blocks the serotonin transporter (SERT) on presynaptic neurons, which reduces the re-uptake of serotonin from the synaptic cleft. By leaving more serotonin available to bind to post-synaptic receptors, mood-regulating pathways become more active. The drug’s onset of action typically occurs within a few weeks, with peak plasma concentrations reached 2-3 hours after an oral dose. Citalopram is metabolised primarily by the liver enzyme CYP2C19 and, to a lesser extent, CYP3A4. Its half-life is about 35 hours, allowing once-daily dosing.
The medication is intended for adults; its safety and efficacy have not been established in children or adolescents for any indication.
Celexa is sometimes prescribed for conditions that lie outside its approved label when a clinician judges the benefits to outweigh the risks.
Off-label use requires supervision by a qualified healthcare professional, and patients should be monitored for efficacy and adverse effects.
These effects are usually transient and may improve within the first two weeks of therapy.
This article provides educational information about Celexa and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Co-administration of two antidepressants increases the risk of serotonin syndrome and should only be considered under close medical supervision. If a switch between agents is needed, a wash-out period is typically required.
Clinical improvement is usually noticeable after 2-4 weeks of consistent dosing, although full therapeutic effects may take up to 8 weeks. Patience and regular follow-up are important.
Patients with known long-QT syndrome or significant cardiac arrhythmias should avoid high doses. The recommended maximum in Hong Kong is 20 mg, and a baseline ECG is advisable for high-risk individuals.
Take the missed tablet as soon as you remember, unless it is close to the time of your next scheduled dose. Do not double the dose to make up for the missed one.
Yes, but keep the medication in its original package with the prescription label, and carry a copy of the prescription. Some countries may require a doctor’s note for controlled psychiatric medicines.
St. John’s wort, an herbal antidepressant, can increase serotonin levels and raise the risk of serotonin syndrome when combined with Celexa. Discuss any supplements with your healthcare provider.
Alterations in serotonin pathways can affect REM sleep, leading to more vivid or unusual dreams. These usually diminish after several weeks of therapy.
Routine blood monitoring is not required for most patients, but liver function tests may be ordered if liver disease is suspected, and electrolytes may be checked in those taking other QT-prolonging drugs.
Citalopram crosses the placenta. While some data suggest relative safety, potential risks to the fetus exist, especially in the third trimester. A risk-benefit discussion with a obstetrician is essential.
Celexa is the brand name; generic citalopram tablets contain the same active ingredient and are typically less expensive. Pricing varies by pharmacy and insurance coverage.
